 | Ewa BarAndziakDepartment of Internal Medicine and Endocrinology, Warsaw Medical University, Warsaw, Poland | Department of Endocrinology, Medical University of Warsaw, Banacha 1A, 02-097 ... |
KOL Resume for Ewa BarAndziak (musculoskeletal system, connective tissue, connective, system, tissue, musculoskeletal)
| Year | |
|---|---|
| 2010 | Department of Internal Medicine and Endocrinology, Warsaw Medical University, Warsaw, Poland |
| 2009 | Department of Endocrinology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland |
| 2007 | Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Banacha, Warsaw, Poland. |
Prominent publications by Ewa BarAndziak
The Enzymatic Activity of Type 1 Iodothyronine Deiodinase (D1) is Low in Liver Hemangioma: A Preliminary Study
[ PUBLICATION ]
Type 1 iodothyronine deiodinase (D1) is a crucial enzyme which converts the prohormone thyroxine (T4) into active tri-iodothyronine (T3). There has been strong evidence that the metabolism of thyroid hormones is disturbed in some neoplastic tissues such as thyroid, renal, and breast cancer. However, there are few available data about D1 enzyme activity in benign tumors such as hemangioma, which is the most common primary liver tumor. Hence this study aimed to determine the enzymatic ...
| Known for Enzymatic Activity | Thyroid Hormones | Iodothyronine Deiodinase | Type 1 | Radioactive Iodine |
BACKGROUND: Genes related to the nuclear factor-kappaB (NF-kappaB), a key transcription factor involved in regulation of immune responses, are interesting candidates for association studies in autoimmune disorders. The aim of this study was to investigate an association of polymorphisms in two genes encoding NF-kappaB inhibitors: IKBL (encoding inhibitor of kappaB-like) and NFKBIA (encoding kappaB inhibitor alpha), withsusceptibility to and phenotype of Graves' disease (GD).
METHODS: A ...
| Known for Graves Disease | Immune Responses | Nf Kappab | Snps Genes | Patients Gd |
Type 1 5'-deiodinase is one of two isoenzymes that participate in conversion of prohormone thyroxine into triiodothyronine (T3). A decrease in type 1 5'-deiodinase expression was observed in renal clear cell carcinoma, thyroid cancer, and lung cancer. The aim of this study was to evaluate type 1 5'-deiodinase activity and mRNA level in breast cancer tissue and non-cancerous surrounding breast tissue. Material was collected from 36 patients undergoing radical mastectomy or local tumor ...
| Known for Breast Cancer | Type 1 | Enzymatic Activity | Prohormone Thyroxine | Expression Regulation |
Ewa BarAndziak: Influence Statistics
| Concept | World rank |
|---|---|
| active tri iodothyronine | #2 |
| d1 liver hemangioma | #2 |
| disturbed neoplastic | #2 |
| d1 disturbed | #2 |
| d1 hemangiomas | #2 |
| d1 activity hemangiomas | #2 |
| disturbed d1 | #2 |
| d1 d1 activity | #3 |
| hemangiomas healthy | #3 |
| benign tumors hemangioma | #5 |
| enzymatic activity d1 | #7 |
| d1 enzyme activity | #8 |
| hormones disturbed | #8 |
| hemangioma activity | #19 |
| rs2071592 | #37 |
| d1 liver | #72 |
| tumors hemangioma | #91 |
Key People For Enzymatic Activity
Ewa BarAndziak:Expert Impact
Concepts for whichEwa BarAndziakhas direct influence:Enzymatic activity, D1 liver hemangioma, D1 d1 activity, Thyroid hormones, D1 activity, Enzymatic activity d1, Liver hemangioma, Prohormone thyroxine.
Ewa BarAndziak:KOL impact
Concepts related to the work of other authors for whichfor which Ewa BarAndziak has influence:Thyroid hormone, Breast cancer risk, Enzymatic activity, Bronchopulmonary dysplasia, Iodothyronine deiodinases, Luteal phase, Otitis media.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |